Abstract | AIMS: Although several antihypertensive agents reduced the carotid intima-media thickness (IMT), it remains unclear whether those agents affect the interadventitial diameter (IAD). We aimed to examine whether cilnidipine, an L/ N-type calcium channel blocker, reduced the common carotid IMT or IAD in post- stroke hypertensive patients. METHODS: The common carotid IMT and IAD were measured at the start of cilnidipine treatment and 12 months from that. The changes in the mean max-IMT or IAD between baseline and the 12-month follow-up were evaluated and compared between the thick group (max-IMT ≥1.1 mm) and the normal group (max-IMT <1.1 mm). RESULTS: A total of 603 post- stroke hypertensive subjects (mean age=69.3 yr, 378 males) were included in the analysis. At baseline, IAD was increased stepwise according to the value of max-IMT (p for trend <0.001). Among them, 326 subjects were followed up for 12 months. The mean max-IMT from baseline to 12 months did not change in the normal group (-0.01 mm, 95% confidence interval [CI] -0.03 to 0.01, n=170), whereas a significant reduction was observed in the thick group (-0.09 mm, 95% CI -0.13 to -0.05, n=156). The mean IAD was significantly reduced during the study period in the normal group (-0.14 mm, 95% CI -0.22 to -0.05) as well as in the thick group (-0.12 mm, 95% CI -0.21 to -0.03). CONCLUSIONS:
Cilnidipine promoted the regression of common carotid IMT in post- stroke hypertensive patients, especially in the thick group. Cilnidipine also reduced the IAD in both normal and thick groups.
|
Authors | Tomohisa Nezu, Naohisa Hosomi, Shiro Aoki, Noriyuki Suzuki, Tsukasa Teshima, Hitoshi Sugii, Shinobu Nagahama, Yoshiki Kurose, Hirofumi Maruyama, Masayasu Matsumoto |
Journal | Journal of atherosclerosis and thrombosis
(J Atheroscler Thromb)
Vol. 25
Issue 6
Pg. 490-504
(Jun 01 2018)
ISSN: 1880-3873 [Electronic] Japan |
PMID | 29225324
(Publication Type: Journal Article)
|
Chemical References |
- Antihypertensive Agents
- Calcium Channel Blockers
- Calcium Channels, L-Type
- Dihydropyridines
- cilnidipine
|
Topics |
- Aged
- Antihypertensive Agents
(adverse effects)
- Calcium Channel Blockers
(therapeutic use)
- Calcium Channels, L-Type
(chemistry)
- Carotid Artery Diseases
(chemically induced, drug therapy)
- Carotid Artery, Common
(drug effects, pathology)
- Carotid Intima-Media Thickness
- Dihydropyridines
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Hypertension
(complications, drug therapy)
- Male
- Prognosis
- Stroke
(complications, drug therapy)
|